A phase I pharmacokinetic, toxicity and dosimetry study of 131I labeled IMMU-4 F(ab')2 in patients with advanced colorectal carcinoma

M. G. Rosenblum, D. Macey, D. Podoloff, L. Kasi, J. Bayouth, J. Cunningham, V. Bhadkamkar, P. Rieger, L. B. Thompson, L. Cheung, C. Pinsky, R. Sharkey, J. L. Murray

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I pharmacokinetic, toxicity and dosimetry study of 131I labeled IMMU-4 F(ab')2 in patients with advanced colorectal carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences